Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21

British Journal of Cancer

Volumn 74, Issue 1, 1996, Pages 115-119

  Tavassoli, M ^a   Steingrimsdottir, H ^b   Pierce, E ^c   Jiang, X ^c   Alagoz, M ^a   Farzaneh, F ^a   Campbell, I G ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Chromosome 5; Loss of heterozygosity; Ovarian cancer; TP53 mutation; Tumour suppressor gene

Indexed keywords

DNA MARKER; MICROSATELLITE DNA;

ARTICLE; CANCER GENETICS; CHROMOSOME 5Q; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE LOCATION; GENE LOSS; GENE MUTATION; HUMAN; HUMAN TISSUE; OVARY CANCER; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0030035692     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.324     Document Type: Article

References (26)

1. ALLAN GJ, COTTRELL S, TROWSDALE J AND FOULKES WD. (1994). Loss of heterozygosity on chromosome 5 in sporadic ovarian carcinoma is a late event and is not associated with mutations in APC at 5q21 22. Hum. Mut., 3, 283-291.
2. BOYNTON RF, BLOUNT PL, YIN J, BROWN VL, HUANG Y, TONG Y, MCDANIEL T, NEWKIRK C, RESAU JH, RASKIND WH, HAGGITT RC, REID B AND MELTZER SJ. (1992). Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. Proc. Natl Acad. Sci. USA, 89, 3385-3388.
3. CAMPBELL IG, NICOLAI HM, FOULKES WD, STAMP GW, ALLAN G, BOYER CM, SENGER G, JONES K, BAST RC JR., SOLOMON E, TROWSDALE J AND BLACK DM. (1994). A novel gene encoding a B-box protein within the BRCA1 region at 17q21.1. Hum. Mol. Genetics, 3, 589-594.
4. CLIBY W, RITLAND S, HARTMANN L, DODSON M, HALLING KC, KEENY G, PODRATZ KC AND JENKINS RB. (1993). Human epithelial ovarian cancer alleloptype. Cancer Res., 53, 2393-2398.
5. D'AMINCO D, CARBONE DP, JOHNSON BE, MELZER SJ AND MINNA J. (1992). Polymorphic sites within the MCC and APC loci reveal very frequent loss of heterozygosity in human small lung cancer. Cancer Res., 52, 1996-1999.
6. EHLEN T AND DUBEAU L. (1990). Loss of heterozygosity on chromosome segments 3p, 6q and 11p in human ovarian carcinomas. Oncogene, 5, 219-223.
7. ENGLEFIELD P, FOULKES WD AND CAMPBELL IG. (1994). Loss of heterozygosity on chromosome 22 in ovarian carcinoma is distal to and is not accompanied by mutations in NF2 at 22q12. Br. J. Cancer, 70, 7486-7488.
8. FOULKES WD, RAGOUSSIS J, STAMP GWH, ALLAN GJ AND TROWSDALE J. (1993a). Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma. Br. J. Cancer, 67, 551-559.
9. FOULKES WD, BLACK DM, STAMP GWH, SOLOMON E AND TROWSDALE J. (1993b). Very frequent loss of heterozygosity throughout chromosome 17 in sporadic ovarian cancer. Int. J. Cancer, 54, 220-225.
10. FOULKES WD, ENGLEFIELD P AND CAMPBELL IG. (1994). Mutation analysis of RASK and the 'FLR exon' of NF1 in sporadic ovarian carcinoma. Eur. J. Cancer, 30A, 528-530.
11. FOULKES WD, STAMP GWH, AFZAL S, LALANI N, MCFARLANE CP, TROWSDALE J AND CAMPBELL IG. (1995). MDM2 overexpression is rare in ovarian carcinoma irrespective of TP53 mutation status. Br. J. cancer, 72, 883-888.
12. GARDNER MJ AND ALTMAN DG. (1989). Statistics with Confidence. BMJ: London.
13. GYAPAY G, MORISSETTE J, VIGNAL A, DIB C, FIZAMES C, MILLASSEAU P, MARC S, BERNARDI G, LATHROP M AND WEISSENBACH J. (1994). The 1993-94 Genethon human genetic linkage map. Nature Genet., 7, 246-249
14. HORII A, NAKATSURU S, MIYOSHI Y, ICHII S, NAGASE H, KATO Y, YANAGISA WA A AND NAKAMURA Y. (1992a). The APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer. Cancer Res., 52, 3231-3233.
15. HORII A, NAKATSURU S, MIYOSHI Y, ICHII S, NAGASE H, ANDO H, YANAGISAWA A, TSUCHIYA E, KATO Y AND NAKAMURA Y. (1992b). Frequent somatic mutations of APC gene in human pancreatic cancer. Cancer Res., 52, 6696-6698.
16. HOSOE S, UENO K, SHIGEDO Y, TACHIBANA I, OSAKI T, KUMAGAI T, TANIO Y, KAWASE I, NAKAMURA Y AND KISHIMOTO T. (1994). A frequent deletion of chromosome 5q21 in advanced small cell and non-small cell carcinoma of the lung. Cancer Res., 54, 1787-1790.
17. KOHLER MF, KERNS B-JM, HUMPHREY PA, MARKS JR, BAST RC AND BERCHUCK A. (1993a). Mutation and overexpression of p53 in early-stage epithelial ovarian cancer. Obstet. Gynecol., 81, 643-650.
18. KOHLER MF, MARKS JR, WISEMAN RW, JACOBS IJ, DAVIDOFF AM, CLARKE-PEARSON DL, SOPER JT, BAST RC AND BERCHUCK A. (1993b). Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer. J. Natl Cancer Inst., 85, 1513-1519.
19. MILNER BJ, ALLAN LA, ECCLES DM, KITCHENER HC, LEONARD RCF, KELLY KF, PARKIN E AND HAITES NE. (1993). p53 is a common genetic event in ovarian carcinoma. Cancer Res., 53, 2128-2132.
20. OKAMOTO A, SAMESHIMA Y, YOKOYAMA S, TERASHIMA Y, SUGIMURA T AND TERADA M. (1991). Frequent allelic losses and mutations of the p53 gene in human ovarian cancer. Cancer Res., 51, 5171-5176.
21. SATO T, SAITO H, MORITA R, KOI S AND NAKAMURA Y. (1991). Allelotype of human ovarian cancer. Cancer Res., 51, 5118-5122.
22. SHEPHERD JH. (1989). Revised FIGO staging for gynaecological cancer. Br. J. Obst. Gynaecol., 96, 889-892.
23. SMITH DR, KHINE K, CHAN CS AND GOH HS. (1995). Tumour suppressor genes in colorectal carcinomas: p53 inactivation is highly associated with allelic loss of chromosome 5q. Int. Oncol., 5, 539-546.
24. TAVASSOLI M, RUHRBERG C, BEAUMONT V, REYNOLDS K, KIRKHAM N, COLLINS WP AND FARZANEH F. (1993). Whole chromosome 17 loss in ovarian cancer. Genes, Chrom. Cancer, 8, 195-198.
25. WEINBERG R. (1992). Tumour suppressor genes. Science, 254, 1138-1145.
26. YANG-FENG TL, HAN H, CHEN KC, LI SB, CLAUS EB, CARCAUGIN ML, CHAMBERS SK, CHAMBERS JT AND SCHWARTZ PE. (1993). Allelic loss in ovarian cancer. Int. J. Cancer, 54, 546-551.